Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Pharma is looking for fewer, scaled providers at an enterprise level to reduce risk and provide a better-integrated service,' ...

On a per-share basis, the Boston-based company said it had profit of 37 cents. Earnings, adjusted for investment costs, were ...

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

Bain Capital Specialty Finance, Inc. (BCSF) Q2 2025 Management View CEO Michael Alexander Ewald highlighted "Q2 net investment income per share was $0.47, representing an annualized yield on book ...

Corrigenda is a technical facility management company based in the UK. Bain Capital portfolio company Apleona has acquired Corrigenda, a technical facility management company based in Fareham, ...

Bain Capital Specialty Finance Inc (NYSE:BCSF) is set to release its Q2 2025 earnings on Aug 5, 2025. The consensus estimate ...

Endeavour has been under pressure to turn around its share price decline, and earlier this week told investors that all ...

Good day, and welcome to the Bain Capital Specialty Finance Second Quarter ended June 30, 2025 Earnings Conference Call. [Operator Instructions]. Please be advised today's program is being recorded.

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

A joint venture between Bain Capital and 11North Partners has purchased a portfolio of 10 open-air retail centers in Florida ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor ...